| Pharmaceutical active ingredients: |
| Dihydroquercetin |
| Available forms, composition and doses of Diquertin: |
| Tablets; Oral; Dihydroquercetin 20 mg |
| Diquertin medical category: |
| Human:Larix Sibirica flavonoids |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V03AX - Other therapeutic products |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Flavir |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Venelbin | Dihydroergotamine Mesylate; Troxerutin | Sanofi-Aventis |
| Divegal | Dihydroergotamine Tartrate | Sanochemia Pharmazeutika |
| Veno | Dihydroergotamine Tartrate; Troxerutin | Sanochemia Pharmazeutika |
| Venotop | Dihydroergotamine Tartrate; Troxerutin | Novartis |
| Wallerox | Dihydroergotamine Tartrate; Troxerutin | Novartis |
| Abiocine | Dihydrostreptomycin | Unidentified Pharmaceutical Company |
| Vibriomycin | Dihydrostreptomycin | Unidentified Pharmaceutical Company |
| Citrocil | Dihydrostreptomycin Sulfate | Reig Jofre |
| Ethamycin | Dihydrostreptomycin Sulfate | Pfizer |
| Cilinafosal Dihidroestreptomicina | Dihydrostreptomycin Sulfate; Ephedrine Hydrochloride; Sulfanilamide Sodium Mesylate | Medical, Spain |